Last update 13 Feb 2026
Ibsa Pharma SAS

Ibsa Pharma SAS

Subsidiary Company|1920|France|
250-500
|
www.laboratoires-genevrier.com

Overview

Tags

Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
COX-1 x COX-21

Related

1
Drugs associated with Ibsa Pharma SAS
Diclofenac Epolamine
Target
COX-1 x COX-2
Mechanism
COX-1 inhibitors [+1]
Active Org.
Nanjing Healthnice Pharmaceutical Technology Co., Ltd.Nanjing Healthnice Pharmaceutical Technology Co., Ltd. [+3]
Originator Org.
IBSA Institut Biochimique SAIBSA Institut Biochimique SA
Active Indication
Acute Pain [+5]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United Kingdom [+1]
First Approval Date28 May 2003
2
Clinical Trials associated with Ibsa Pharma SAS
EUCTR2009-014276-22-CZ
/ TerminatedPhase 3
Prospective, randomised, multi-centre, blind-observer, controlled, parallel-group study comparing the efficacy and the safety of DERMAGEN® versus conventionnal treatment in the treatment of diabetic neuropthic foot ulcer
EUCTR2008-005518-29-FR
/ RecruitingPhase 2
An exploratory, open-label, intra-individual,active- controlled study comparing the efficacy and safety of Betesil versus Daivobet for the treatment of chronic plaque psoriasis
100 Clinical Results associated with Ibsa Pharma SAS
Login to view more data
0 Patents (Medical) associated with Ibsa Pharma SAS
Login to view more data
100 Deals associated with Ibsa Pharma SAS
Login to view more data
100 Translational Medicine associated with Ibsa Pharma SAS
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Apr 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free